Rifampicin in DrugAge

Summary

SpeciesAssaysAvg Lifespan Change (%)Maximum Lifespan Change (%)
Caenorhabditis elegans1056.1
Summary Total Assays: 10 Max: 56.1 Max:

Results for Rifampicin

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance

Selected Lifespan Change:

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance Reference

References

Primary References
Golegaonkar, S et al. (2015) Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans. Aging Cell 14(3)463-473 PubMed

DGIdb human gene-drug interactions for Rifampicin

Entrez Gene Symbol Gene Name Interaction Source Interaction Type GenAge Interactions

Stitch DB human protein-drug interactions for Rifampicin

The data below is based on a Stitch DB API call for human protein-drug interactions for Rifampicin

Up to 20 direct protein and drug interactions are displayed, having a medium confidence score (0.450) or above.

Rifampicin

Displayed below are the associated biological networks for each of the top 20 direct Rifampicin protein interactors.

Ensembl Id StringDB Id